Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomatitis 5Lymphoma 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Multiple Myeloma 3Mucositis 3Leukemia 3Hodgkin Disease 3Head and Neck Neoplasms 3Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Graft vs Host Disease 2Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma 1Recurrence 1Radiation Injuries 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pain 1Oral Ulcer 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1

Interventions

Carboplatin 235Pemetrexed 214Paclitaxel 160Cisplatin 150pembrolizumab 145Erlotinib Hydrochloride 141Docetaxel 133Gemcitabine 94Bevacizumab 85Nivolumab 72Radiotherapy 62atezolizumab 40Radiosurgery 37Afatinib 37osimertinib 35130-nm albumin-bound paclitaxel 35Cetuximab 34durvalumab 33Ipilimumab 32Gefitinib 31Albumin-Bound Paclitaxel 29Vinorelbine 23Taxes 22Etoposide 20Crizotinib 19Radiation 17Sorafenib 16Cyclophosphamide 16Dexamethasone 15Magnetic Resonance Spectroscopy 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Non-Small-Cell Lung × Fibroblast Growth Factor 7 × Clear all
NCT00094861 2017-03-14

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Swedish Orphan Biovitrum

Phase 2 Completed
100 enrolled 19 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Deglutition Disorders, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡